Cargando…

HTA’d in the USA: A Comparison of ICER in the United States with NICE in England and Wales

BACKGROUND: The Institute for Clinical and Economic Review (ICER) has gained recognition for performing independent health technology assessments (HTAs) that include the cost-effectiveness of selected new technologies in the United States. ICER has similarities with the National Institute for Health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thokala, Praveen, Carlson, Josh J., Drummond, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391099/ https://www.ncbi.nlm.nih.gov/pubmed/32857653 http://dx.doi.org/10.18553/jmcp.2020.26.9.1162

Ejemplares similares

Worldwide HTA access to ICER's cost-effectiveness models
Publicado: (2020)

ICER’s Version of HTA Is Positioned to Guide U.S. Health Care Reform
por: Watkins, John B.
Publicado: (2020)

HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications
por: Kruzikas, Denise T, et al.
Publicado: (2020)

Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
por: Marsh, Kevin, et al.
Publicado: (2018)

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease
por: Jørgensen, Jesper, et al.
Publicado: (2018)

Mandatory implementation of NICE Guidelines for the care of bipolar disorder and other conditions in England and Wales
por: Morriss, Richard
Publicado: (2015)

The use of real-world evidence in ICER’s scoping process and clinical evidence assessments
por: Jiao, Boshen, et al.
Publicado: (2020)

1951 Influenza Epidemic, England and Wales, Canada, and the United States
por: Viboud, Cécile, et al.
Publicado: (2006)

Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort
por: Turner, Sheila, et al.
Publicado: (2015)

A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines
por: Malik, Rizwan, et al.
Publicado: (2013)

Trends in eye cancer mortality among adults in the USA and England and Wales.
por: Foss, A. J., et al.
Publicado: (1996)

Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States
por: Eggo, Rosalind M., et al.
Publicado: (2011)

The Present State of Lunacy in England and Wales
Publicado: (1858)

The Present State of Lunacy in England and Wales
Publicado: (1857)

Should Drug Companies Engage with ICER? An Empirical Analysis of How Often Manufacturers Engage with ICER and Whether Engagement May Influence ICER’s Cost-Effectiveness Estimates
por: Breslau, Rachel Milstein, et al.
Publicado: (2022)

Civil Commitment Standards and Patient Mix in England/Wales, Italy, and the United States.
por: Segal, Steven P.
Publicado: (1989)

Is ‘viability’ viable? Abortion, conceptual confusion and the law in England and Wales and the United States
por: Romanis, Elizabeth Chloe
Publicado: (2020)

ICER is requisite for Th17 differentiation
por: Yoshida, Nobuya, et al.
Publicado: (2016)

The ICER review is in: hope amidst uncertainty
por: Begolka, Wendy Smith, et al.
Publicado: (2022)

The evolution of ICER’s review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER’s reports
por: Ronquest, Naoko A, et al.
Publicado: (2021)

Lunacy in England and Wales
Publicado: (1882)

Smallpox in England and Wales
Publicado: (1924)

Transportation: De-icers Add Sweet to Salt
por: Tenenbaum, David
Publicado: (2008)

ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019)

Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: Addressing treatment outside the current NICE guidance
por: Chiu, Yee, et al.
Publicado: (2012)

Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
por: Lebioda, Andrea, et al.
Publicado: (2014)

An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
por: Kanavos, Panos, et al.
Publicado: (2019)

Coroners' records in England and Wales
por: Bowman, Marion
Publicado: (1990)

Hepatitis E in England and Wales
por: Lewis, Hannah C., et al.
Publicado: (2008)

The Prevalence of Lunacy in England and Wales
Publicado: (1902)

Condition of Lunacy in England and Wales
Publicado: (1876)

General Survey of England and Wales
por: Burnett, Napier
Publicado: (1920)

England, Wales and Scotland Awakening
Publicado: (1920)

Evidence for tuning adipocytes ICER levels for obesity care
por: Brajkovic, Saška, et al.
Publicado: (2012)

ICER update to pricing models of remdesivir for COVID-19
Publicado: (2020)

ICER's timelines for assessments extended due to COVID-19
Publicado: (2020)

ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
por: Franklin, Meg, et al.
Publicado: (2020)

Survey of cardiac output monitoring in intensive care units in England and Wales
por: Esdaile, B, et al.
Publicado: (2005)

Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund.
por: Sharma, Tarang, et al.
Publicado: (2018)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vo40ttr1aq84ch6jpuosk4gh01